Choongwae with Export Sales Growth Prospect

Published: 2005-03-03 06:58:00

Updated: 2005-03-03 06:58:00

From a recent market analysis on the domestic pharmaceutical firms released by Hanyang Securities, Choongwae Pharma is selected as the top prospect for its international growth potential for the current year and forward.

Analyst Kim Hee-sung of Hanyang Securities explained that, while the majo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK